Breaking News Instant updates and real-time market news.

TEVA

Teva

$19.12

0.31 (1.65%)

07:18
02/13/19
02/13
07:18
02/13/19
07:18

Teva says continues to see 2019 as 'trough' for business

  • 13

    Feb

TEVA Teva
$19.12

0.31 (1.65%)

01/23/19
01/23/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Walmart (WMT) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Simeon Gutman citing his belief that Walmart U.S. can now generate sales growth without sacrificing margins, unlike most retailers. 2. Teva (TEVA) upgraded to Buy from Neutral at UBS and to Neutral from Underweight at Piper Jaffray. 3. D.R. Horton (DHI) upgraded to Buy from Neutral at Mizuho with analyst Haendel St. Juste saying stock selectivity is becoming more important in these latter stages of the housing cycle and larger platforms with price point diversification and strong balance sheets will be rewarded. 4. Logitech (LOGI) upgraded to Overweight from Neutral at JPMorgan and to Hold from Sell at Maxim. 5. Lamb Weston (LW) upgraded to Buy from Hold at Stifel with analyst Christopher Growe saying he is confident in the "growth profile of the business continuing amidst the very strong operating conditions in the category." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/25/19
PIPR
01/25/19
NO CHANGE
PIPR
Report that CVS excluded Amgen's Aimovig 'greatly exaggerated,' says Piper
Piper Jaffray analyst Christopher Raymond kept an Overweight rating and $220 price target on Amgen (AMGN) following a Reuters report from earlier on Friday which stated that CVS (CVS) has excluded Amgen's Aimovig from its formulary. The analyst called the report "Friday afternoon clickbait" and noted that while CVS currently provides preferred status to Teva's (TEVA) Ajovy and Eli Lilly's (LLY) Emgality, this was made public in late 2018. In a check with management, Raymond found out the decision only encompasses about one-third of CVS network, that CVS is actively working to improve this access, and that 70% of commercial migraine patients have contracted access to Aimovig. Raymond concluded that this was "not something to worry about" in his view, and did not change his Q4, FY19, or FY20 estimates on Aimovig. In Friday trading, shares of Amgen were down just over 1% to $198.77.
01/30/19
WELS
01/30/19
NO CHANGE
WELS
Wells says Novartis report read-through 'neutral to negative' for Mylan, Teva
After Novartis' (NVS) Sandoz generics unit reported Q4 sales were down 2% in constant currency, due to a 7% decline in price and 5% increase in volume, Wells Fargo analyst David Maris noted that the majority of the price erosion came from the U.S. While the 2% decline was a sequential improvement from down 4% in Q3, Novartis was up against an easy comparison in the year ago period, Maris added. His view is that the U.S. generic market has not materially changed or improved at this point and he contends the report has a "neutral to negative read-through" relative to investors' expectations for Mylan (MYL) and Teva (TEVA).
02/01/19
WELS
02/01/19
NO CHANGE
Target $46
WELS
Market Perform
Perrigo's ProAir opportunity 'may be vaporizing,' says Wells Fargo
Wells Fargo analyst David Maris noted that GlaxoSmithKline (GSK) launched an authorized generic of Ventolin on January 15 and he has now learned that Teva (TEVA) may have "surprisingly launched" an authorized generic of ProAir in response to the generic Ventolin pressure prior to Perrigo's (PRGO) approval. Pricing pressure from generic Ventolin, in addition to the launch of an authorized generic well ahead of Perrigo's own generic ProAir launch, seem to have significantly diminished Perrigo's generic ProAir opportunity, Maris tells investors. He keeps a Market Perform rating and $46 price target on Perrigo shares.

TODAY'S FREE FLY STORIES

SEM

Select Medical

$15.49

-0.11 (-0.71%)

16:40
02/21/19
02/21
16:40
02/21/19
16:40
Hot Stocks
Select Medical extends $500M share repurchase program »

Select Medical did not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

ULH

Universal Logistics

$23.66

(0.00%)

16:39
02/21/19
02/21
16:39
02/21/19
16:39
Earnings
Universal Logistics reports Q4 EPS 32c, consensus 41c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

CASA

Casa Systems

$11.96

-0.02 (-0.17%)

16:39
02/21/19
02/21
16:39
02/21/19
16:39
Hot Stocks
Casa Systems to acquire NetComm Wireless »

NetComm Wireless Limited…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 13

    Mar

BIIB

Biogen

$320.99

-14.02 (-4.18%)

16:39
02/21/19
02/21
16:39
02/21/19
16:39
Downgrade
Biogen rating change  »

Biogen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 28

    May

GMED

Globus Medical

$47.68

0.05 (0.10%)

16:38
02/21/19
02/21
16:38
02/21/19
16:38
Earnings
Globus Medical reports Q4 EPS 43c, consensus 39c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 06

    Mar

CASA

Casa Systems

$11.96

-0.02 (-0.17%)

16:38
02/21/19
02/21
16:38
02/21/19
16:38
Earnings
Casa Systems sees FY19 EPS 30c-40c, consensus 73c »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 13

    Mar

REGN

Regeneron

$418.66

-3.9 (-0.92%)

16:38
02/21/19
02/21
16:38
02/21/19
16:38
Downgrade
Regeneron rating change  »

Regeneron downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 11

    Mar

  • 11

    Mar

  • 28

    Apr

  • 13

    May

MBIN

Merchants Bancorp

$21.92

-0.08 (-0.36%)

16:38
02/21/19
02/21
16:38
02/21/19
16:38
Hot Stocks
Merchants Bancorp raises quarterly dividend 17% to 7c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HF

HFF Inc.

$42.40

-0.26 (-0.61%)

16:38
02/21/19
02/21
16:38
02/21/19
16:38
Earnings
HFF Inc. reports Q4 EPS $1.11, consensus $1.04 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

HASI

Hannon Armstrong

$23.67

0.16 (0.68%)

16:37
02/21/19
02/21
16:37
02/21/19
16:37
Hot Stocks
Hannon Armstrong announces changes on leadership team »

Hannon Armstrong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

SEM

Select Medical

$15.49

-0.11 (-0.71%)

16:37
02/21/19
02/21
16:37
02/21/19
16:37
Earnings
Select Medical backs FY19 EPS view 97c-$1.13, consensus $1.10 »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

BOOM

DMC Global

$35.37

0.04 (0.11%)

16:37
02/21/19
02/21
16:37
02/21/19
16:37
Earnings
Breaking Earnings news story on DMC Global »

DMC Global sees Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Mar

BIDU

Baidu

$171.72

0.64 (0.37%)

16:36
02/21/19
02/21
16:36
02/21/19
16:36
Hot Stocks
Baidu reports Baidu App DAUs reach 161M in December, up 24% y/y »

Baidu App daily active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 20

    Mar

CPB

Campbell Soup

$35.44

0.26 (0.74%)

16:36
02/21/19
02/21
16:36
02/21/19
16:36
Hot Stocks
Campell Soup to sell Campbell Fresh Plant to JGC affiliate »

Campbell Soup announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    May

MGM

MGM Resorts

$28.34

-0.48 (-1.67%)

16:36
02/21/19
02/21
16:36
02/21/19
16:36
Hot Stocks
MGM reaffirms previously announced 2020 free cash flow targets »

MGM Resorts reaffirmed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

CASA

Casa Systems

$11.96

-0.02 (-0.17%)

16:36
02/21/19
02/21
16:36
02/21/19
16:36
Earnings
Casa Systems reports Q4 EPS 20c, consensus 14c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 13

    Mar

BOOM

DMC Global

$35.37

0.04 (0.11%)

16:36
02/21/19
02/21
16:36
02/21/19
16:36
Earnings
DMC Global reports Q4 EPS 46c, consensus 36c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Mar

WRB

W. R. Berkley

$82.37

-0.16 (-0.19%)

16:36
02/21/19
02/21
16:36
02/21/19
16:36
Hot Stocks
W. R. Berkley announces 3-for-2 stock split »

W. R. Berkley announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:35
02/21/19
02/21
16:35
02/21/19
16:35
General news
Fed Balance Sheet Level data reported »

Week of 2/20 Fed Balance…

16:35
02/21/19
02/21
16:35
02/21/19
16:35
General news
Money Supply M2 Weekly Change data reported »

Week of 2/11 Money Supply…

16:35
02/21/19
02/21
16:35
02/21/19
16:35
General news
Quarterly Services Report (Advance) Information Revenue data reported »

Quarterly Services Report…

16:35
02/21/19
02/21
16:35
02/21/19
16:35
General news
Quarterly Services Report (Advance) Information Revenue data reported »

Quarterly Services Report…

MGM

MGM Resorts

$28.34

-0.48 (-1.67%)

16:35
02/21/19
02/21
16:35
02/21/19
16:35
Hot Stocks
MGM announces resignation of CFO Dan D'Arrigo, appoints Corey Sanders to role »

MGM Resorts announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

SUNS

Solar Senior Capital

$16.81

0.05 (0.30%)

16:35
02/21/19
02/21
16:35
02/21/19
16:35
Earnings
Solar Senior Capital reports Q4 NII 35c, consensus 35c »

At December 31, 2018, net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

OPNT

Opiant Pharmaceuticals

$14.65

-0.25 (-1.68%)

16:35
02/21/19
02/21
16:35
02/21/19
16:35
Hot Stocks
Breaking Hot Stocks news story on Opiant Pharmaceuticals »

Opiant Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.